← Eichor
Condition: Prolactin Excess Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prolactin Excess

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Phase 3 · 16 location(s) · University of Sao Paulo General Hospital · NCT07463235Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Phase 4 · 1 location(s) · University Hospital, Basel, Switzerland · NCT07045935A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
Phase 3 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07124221
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.